CollaGenex Pharmaceuticals to Present at the Lazard Capital Markets

MSN MoneyCentral - acquired the rights to develop and commercialize becocalcidiol, a patented Vitamin D analogue developed by QuatRx Pharmaceuticals Company that is currently in Phase II clinical trials for the topical treatment of mild to moderate psoriasis. Read More